Paediatric Oncology Literature

Monday, 15 October 2012

Febrile Neutropenia Guidelines 


Phillips R, Hancock B, Graham J, Bromham N, Jin H, Berendse S. Prevention and management of neutropenic sepsis in patients with cancer: summary of NICEguidance. BMJ. 2012 Sep 19;345:e5368. doi: 10.1136/bmj.e5368.
Posted by Ramandeep Arora at 02:57
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: England, Febrile Neutropenia, Guidelines, Supportive Care

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Labels

abandonment (3) Bone tumours (3) central america (1) Chemotherapy (3) Clinical Trial (1) CNS Tumours (4) COG (3) delayed diagnosis (2) England (5) Epidemiology (10) Febrile Neutropenia (2) GCT (1) Genetics (1) Guidelines (5) Histiocytosis (1) Hodgkin Disease (2) Incidence (6) India (12) Leukaemia (5) Medulloblastoma (1) mortality (3) MRD (2) Non-Hodgkin's Lymphoma (1) PHO IAP (1) PODC (2) Radiology (1) Radiotherapy (3) Raman (3) Randomised Controlled Trial (5) relapse (1) Report (2) retinoblastoma (1) Review (1) SIOP (3) soft tissue sarcoma (1) south america (1) Supportive Care (2) Trends (1) TYA (3) UK (1) Wilms Tumour (1)

Blog Archive

  • ►  2013 (4)
    • ►  April (2)
    • ►  February (1)
    • ►  January (1)
  • ▼  2012 (26)
    • ►  December (1)
    • ►  November (2)
    • ▼  October (3)
      • Delayed Diagnosis Review
      • Febrile Neutropenia Guidelines
      • Wilms PODC Guidelines
    • ►  September (20)

About Me

My photo
Ramandeep Arora
I have done my initial paediatric training in India and then went to UK for further training in paediatric oncology and cancer epidemiology. Having spent 11 years there I moved back to India in 2013 and have joined Max Healthcare, New Delhi as a consultant paediatric oncologist. My main area of interest is childhood cancer with a specific focus on paediatric oncology in developing countries and childhood cancer epidemiology. I am also interested in understanding the phenomenon of refusal and abandonment in treatment of childhood cancer in developing countries and to develop interventions to deal with it.
View my complete profile
Simple theme. Powered by Blogger.